HIV is not associated with preterm delivery, though antiretroviral therapy is, but hepatitis C may be a potential risk factor.
An analysis indicates that immune-related adverse events may be more common than initially reported in the clinical trials for these therapies.
Top news of the day from across the health care landscape.
Detecting hepatitis C RNA in peripheral blood mononuclear cells or liver cells in patients who are negative for viral RNA raises questions about the risk of transmission to other individuals.
Phase 2 data show positive results for a therapy including 2 immune checkpoint inhibitors and chemotherapy.
Top news of the day from across the health care landscape.
Early detection is vital to more patients with hepatitis C virus being eligible for increasingly efficient direct-acting antiviral treatment options.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.